COR COMPLETES IPOCor Therapeutics Inc. on Thursday completed an initial publicoffering of stock, raising $15 million on the sale of 2 millionshares at $7.50.

Cor had hoped to sell 2.5 million shares at between $9 and $11.Market conditions led the company to reduce that goal to 1.5million shares at between $7 and $9 in its preliminaryprospectus June 6, said Lee Douglas, chief financial officer.

Stock of the South San Francisco, Calif., company(NASDAQ:CORR), which focuses on acute cardiovasculardisease, closed at $8.13.


Favorable reports issued by several analysts on Thursdaypushed Amgen Inc. (NASDAQ:AMGN) stock up $7 to close at$117.75.

(c) 1997 American Health Consultants. All rights reserved.